(Adnkronos) - “Se si ha l’alterazione genetica il rischio di trasmetterla ai propri figli è di circa il 50%”. Così, Emanuela Lucci Cordisco, genetista Medico alla Fondazione Policlinico Universitario A. Gemelli IRCCS di Roma e Ricercatore Universitario dell’Università Cattolica del Sacro Cuore, a margine della conferenza stampa in cui si è parlato della nuova era nel trattamento delle forme ereditarie del tumore della mammella, in particolare in presenza di mutazione dei geni BRCA, grazie a una terapia mirata, olaparib, di cui l’AIFA ne ha approvato la rimborsabilità.
Category
🗞
NewsTranscript
00:00 (upbeat music)
00:03 (speaking in foreign language)
00:07 (speaking in foreign language)
00:11 (speaking in foreign language)
00:15 (speaking in foreign language)
00:20 (speaking in foreign language)
00:24 (speaking in foreign language)
00:28 (speaking in foreign language)
00:32 (speaking in foreign language)
00:35 (speaking in foreign language)
00:39 (speaking in foreign language)
00:43 (speaking in foreign language)
00:47 (speaking in foreign language)
00:51 (speaking in foreign language)
00:55 (speaking in foreign language)
00:59 (speaking in foreign language)
01:03 (speaking in foreign language)
01:07 (speaking in foreign language)
01:11 (speaking in foreign language)
01:15 (speaking in foreign language)
01:19 (speaking in foreign language)
01:22 (speaking in foreign language)
01:26 of about 50%.